AHA Presidential Advisory: Urgent Challenges in Cardiovascular Disease
30 Jan, 2019 | 00:44h | UTCNews Release: Lagging drug innovation, variations in quality of care and rising health care costs remain major barriers in fight against cardiovascular disease (free)
Commentaries: AHA issues ‘urgent’ call to action: 5 things to know – Cardiovascular Business (free) AND AHA Warns of Stagnating CVD Gains, Barriers to Access, and Dismal Drug Pipeline – TCTMD (free)